Skip to content

Clinical trials

Choroidal Neovascularization trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Country / region: Germany Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20101
20122
20133
20141
20152
20191
20201
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Novartis2
Ophthotech Corporation2
University Hospital, Bonn2
AbbVie1
EyeBiotech Ltd.1
Pfizer1
Quark Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization18
Macular Degeneration13
Vision Disorders5
Wet Macular Degeneration5
Eye Diseases4
Retinal Degeneration4
Retinal Diseases4
Geographic Atrophy3
Angioid Streaks2
Pseudoxanthoma Elasticum2

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.